200 related articles for article (PubMed ID: 30422914)
1. Effects of ABO Matching of Platelet Transfusions in Critically Ill Children.
Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC; ;
Pediatr Crit Care Med; 2019 Feb; 20(2):e61-e69. PubMed ID: 30422914
[TBL] [Abstract][Full Text] [Related]
2. International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis.
Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
Pediatr Crit Care Med; 2019 Jul; 20(7):e342-e351. PubMed ID: 31107379
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Plasma and Platelet Transfusions on Extracorporeal Membrane Oxygenation: A Subgroup Analysis of Two Large International Point-Prevalence Studies and the Role of Local Guidelines.
Nellis ME; Saini A; Spinella PC; Davis PJ; Steiner ME; Tucci M; Cushing M; Demaret P; Stanworth SJ; Leteurtre S; Karam O;
Pediatr Crit Care Med; 2020 Mar; 21(3):267-275. PubMed ID: 31644453
[TBL] [Abstract][Full Text] [Related]
4. Platelet Transfusion Practices in Critically Ill Children.
Nellis ME; Karam O; Mauer E; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
Crit Care Med; 2018 Aug; 46(8):1309-1317. PubMed ID: 29727368
[TBL] [Abstract][Full Text] [Related]
5. ABO and platelet transfusion revisited.
Heal JM; Rowe JM; Blumberg N
Ann Hematol; 1993 Jun; 66(6):309-14. PubMed ID: 8318561
[TBL] [Abstract][Full Text] [Related]
6. ABO incompatible platelets: risks versus benefit.
Dunbar NM; Ornstein DL; Dumont LJ
Curr Opin Hematol; 2012 Nov; 19(6):475-9. PubMed ID: 22914587
[TBL] [Abstract][Full Text] [Related]
7. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
Sintnicolaas K; Löwenberg B
Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
Heal JM; Blumberg N; Masel D
Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
[TBL] [Abstract][Full Text] [Related]
9. Effect of platelet storage duration on clinical outcomes and incremental platelet change in critically ill children.
Nellis ME; Spinella PC; Tucci M; Stanworth SJ; Steiner ME; Cushing MM; Davis PJ; Karam O;
Transfusion; 2020 Dec; 60(12):2849-2858. PubMed ID: 32959409
[TBL] [Abstract][Full Text] [Related]
10. Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study.
Pavenski K; Warkentin TE; Shen H; Liu Y; Heddle NM
Transfusion; 2010 Jul; 50(7):1552-60. PubMed ID: 20210928
[TBL] [Abstract][Full Text] [Related]
11. Correlation of platelet crossmatch results by Solid Phase Red Cell Adherence Assay (SPRCA) with post-transfusion platelet count increment in adult hemato-oncology patients of a tertiary care oncology centre in India.
Desai P; Sontakke P; Rajadhyaksha S; Navkudkar A
Transfus Apher Sci; 2020 Oct; 59(5):102842. PubMed ID: 32586771
[TBL] [Abstract][Full Text] [Related]
12. ABO-incompatible platelets are associated with increased transfusion reaction rates.
Malvik N; Leon J; Schlueter AJ; Wu C; Knudson CM
Transfusion; 2020 Feb; 60(2):285-293. PubMed ID: 31912889
[TBL] [Abstract][Full Text] [Related]
13. Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry.
Ning S; Barty R; Liu Y; Heddle NM; Rochwerg B; Arnold DM
Chest; 2016 Sep; 150(3):516-23. PubMed ID: 27102183
[TBL] [Abstract][Full Text] [Related]
14. Platelet transfusion practice and platelet refractoriness for a cohort of pediatric oncology patients: A single-center study.
Lieberman L; Liu Y; Barty R; Heddle NM
Pediatr Blood Cancer; 2020 Dec; 67(12):e28734. PubMed ID: 32975362
[TBL] [Abstract][Full Text] [Related]
15. Platelet Transfusions in the PICU: Does Disease Severity Matter?
Saini A; West AN; Harrell C; Jones TL; Nellis ME; Joshi AD; Cowan KM; Gatewood CW; Ryder AB; Reiss UM
Pediatr Crit Care Med; 2018 Sep; 19(9):e472-e478. PubMed ID: 29927877
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of platelet cross-matching in the management of patients refractory to platelet transfusions.
Salama OS; Aladl DA; El Ghannam DM; Elderiny WE
Blood Transfus; 2014 Apr; 12(2):187-94. PubMed ID: 24931840
[TBL] [Abstract][Full Text] [Related]
17. Acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: Two case reports.
Zulkeflee RH; Hassan MN; Hassan R; Saidin NIS; Zulkafli Z; Ramli M; Abdullah M; Iberahim S; Roslan W; Mohd Noor NH; Wan Ab Rahman WS
Transfus Apher Sci; 2023 Jun; 62(3):103658. PubMed ID: 36805153
[TBL] [Abstract][Full Text] [Related]
18. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Josephson CD; Castillejo MI; Grima K; Hillyer CD
Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
[TBL] [Abstract][Full Text] [Related]
19. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
[TBL] [Abstract][Full Text] [Related]
20. Cross-match-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
Elhence P; Chaudhary RK; Nityanand S
Blood Transfus; 2014 Apr; 12(2):180-6. PubMed ID: 24333069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
